The Distribution and Outcomes of the 21-Gene Recurrence Score in T1-T2N0 Estrogen Receptor-Positive Breast Cancer With Different Histologic Subtypes

@article{Wang2018TheDA,
  title={The Distribution and Outcomes of the 21-Gene Recurrence Score in T1-T2N0 Estrogen Receptor-Positive Breast Cancer With Different Histologic Subtypes},
  author={J. Wang and Zhen-Yu He and Yong Dong and Jia-yuan Sun and Wen-wen Zhang and San-Gang Wu},
  journal={Frontiers in Genetics},
  year={2018},
  volume={9}
}
Background: The clinical value of 21-gene recurrence score (RS) in various breast cancer histologic subtypes is not well established. Aims: To assess the distribution and outcomes of the 21-gene RS among various T1-T2N0 estrogen receptor-positive breast cancer histologic subtypes. Methods: Using the Surveillance, Epidemiology and End Results database, we investigated the distribution and outcomes of the 21-gene RS among various breast cancer histologic subtypes between 2004 and 2015. The… Expand
LobSig is a multigene predictor of outcome in invasive lobular carcinoma
Invasive lobular carcinoma of the breast: the increasing importance of this special subtype

References

SHOWING 1-10 OF 45 REFERENCES
Distribution of 21-Gene Recurrence Scores Among Breast Cancer Histologic Subtypes.
Impact of the 21-gene recurrence score on outcome in patients with invasive lobular carcinoma of the breast
21-Gene recurrence score and locoregional recurrence in lymph node-negative, estrogen receptor-positive breast cancer
Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor-positive breast cancer: results from NSABP B-14 and NSABP B-20.
  • E. Mamounas, G. Tang, +7 authors N. Wolmark
  • Medicine
  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2010
Clinical characteristics of different histologic types of breast cancer
Is There a Role for Oncotype Dx Testing in Invasive Lobular Carcinoma?
Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast: combined results of 15 International Breast Cancer Study Group clinical trials.
...
1
2
3
4
5
...